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Abstract 
Aims 
To assess the effectiveness of haemodialysis sodium profiling techniques 
Background 
Haemodialysis has improved in recent years, however, despite such improvements, intra-
dialytic hypotensive episodes still persist which can lead to a reduction in the overall 
effectiveness of the treatment.  Profiling sodium levels during dialysis can improve vascular 
refilling and therefore may prevent hypotensive events.  A number of profiling methods exist 
and this meta-analysis set out to examine the effectiveness of these methods. 
Design 
A review and meta-analysis analytical framework was used. 
Methods 
A search was conducted using Medline, Embase and CINAHL, Scopus and Web of 
Knowledge between 1946 and 2014 of published English-language peer reviewed 
randomised control studies. In total 10 articles were retrieved and included in the review.  All 
data was abstracted with a standardised data collection form.   
Review Methods 
Stata 11.2 (Stata Corp) was used to analyse the data.  Actual numbers of hypotensive events 
were pooled between studies.  Analysis of subgroups was performed on sodium profile type. 
The data were further investigated using meta-regression. Publication bias was also tested. 
Results 
Stepwise profiling was shown to be statistically significantly effective in reducing 
intradialytic episodes.  Results demonstrated that linear sodium profiling was not effective in 
reducing hypotensive events during dialysis.   
 
Conclusion 
This review has shown that using stepwise profiling is more effective at reducing intra-
dialytic symptoms than other profiling methods. There was no evidence that linear profiling 
method was any more effective than conventional dialysis and in fact the results showed the 
reverse. 
 
Body of Article 
INTRODUCTION 
End stage renal failure (ESRF) is the result of deterioration in kidney function (1).  Kidney 
transplantation is the most effective treatment for end stage renal failure (2).  However, due to 
the limited number of organ donors and difficulties with tissue matching, patients with ESRF 
may require medical management with dialysis for some time.   
Dialysis treatment has improved in recent years with machines that allow profiling of ultra 
filtration and sodium (tailoring dialysis treatment to individual needs) and more choices in 
dialysate fluid composition for removal of toxins (3).  Despite such improvements in care 
delivery, treatment is not asymptomatic for all patients and symptoms of hypotension are 
common in up to 20% of dialysis sessions (4).  Hypotensive episodes during dialysis can lead 
to shortening of treatment sessions reducing the effectiveness of the overall treatment.  There 
is evidence to suggest that survival of dialysis patients is related to the delivered dose (5-9), 
and therefore it is essential that effective dialysis treatment is maintained. 
Conventional dialysis uses constant sodium levels throughout the dialysis session. Profiling 
involves altering the sodium level during the course of dialysis treatment.  Profiling sodium 
levels during dialysis can improve vascular refilling and therefore may prevent hypotensive 
events during dialysis (10).    A number of profiling methods are used in clinical practice; 
however the UK Renal Association (11) recommends that the stepwise method be used in 
preventing symptomatic dialysis. 
There have been a number of randomised trials that have tested whether sodium profiling can 
reduce intradialytic hypotensive episodes; however some of these trials have been small (12, 13) 
and some have failed to show any statistical significance (14-16).  Issues of selecting 
participants that are not prone to hypotensive episodes during dialysis also exists.  There is 
some uncertainty if the effect estimates are influenced by the recruitment of only 
haemodynamically stable patients as included in two studies (12, 17).  It would seem plausible 
that if these patients do not usually have hypotensive episodes during conventional dialysis 
then this is unlikely to change during profiled dialysis. 
The review 
 AIM 
The aim of this review and meta-analysis was to synthesize the ﬁndings of primary research 
comparing sodium profiling techniques in minimising intradialytic hypotensive episodes. 
Using a PICOS framework (18) the review components were – Population: patients requiring 
haemodialysis, Intervention: sodium profiling techniques; Comparison: conventional dialysis; 
Outcome: number of intra-dialytic hypotensive events; Study design: meta-analysis. 
METHODS  
Design 
A review and meta-analysis analytical framework was used. Summary statistical data were 
obtained from a set of studies and effect sizes and variance were calculated.  Effect sizes 
were weighted inversely according to their variance.  
A search was conducted using Medline, Embase and CINAHL, Scopus and Web of 
Knowledge (1946 to 2015) using the keywords: dialysis, haemodialysis, hypotension, 
intradialytic hypotension, sodium profile, stepwise profile, linear profile. These keywords 
were used in combination using ‘OR’ and ‘AND’ to identify all relevant papers.  The search 
was limited to primary peer reviewed published manuscripts in English language. Only 
studies with a control or referent group were included in the review.  There was no restriction 
based on dialysis prescription, gender, age or ethnicity.  All sodium profiling techniques that 
could be found were included in the review. Publications had to include the number of intra-
dialytic hypotensive episodes.  There were no date restrictions.  Reference lists from 
published papers were also manually assessed for further relevant papers. Hand searches of 
specific Journals were not conducted.  
After duplicate papers were discarded, a total of 146 papers were assessed for relevance 
(Figure 1).  Screening of articles was performed by reviewing the title and abstract.  A copy 
of the articles that met the inclusion criteria based on the title and abstract screen were 
obtained for the full review.  Full text eligibility was then screened with reasons for exclusion 
annotated and tracked.   
Search outcome 
In total ten articles were found and included in the meta-analysis (12-17, 19-22).   
Quality Appraisal 
The methodological quality of the studies was assessed using the Cochrane Collaboration’s 
tool for assessing risk of bias (Table 1). The ten papers were subjected to a quality appraisal 
process to ensure minimum research criteria were met(23). Sodium profile findings from three 
papers (13, 19, 22) were considered separately for outcomes as two interventions were tested 
against the control. 
Outcome measurements and sensitivity analysis 
Data was collected by one researcher. Outcomes were analysed on an intention-to-treat basis. 
The primary outcome was number of hypotensive events. Sensitivity analysis assessing the 
robustness of the results included heterogeneity analysis and subgroups analyses of sodium 
profile types.  
As regards profile type, the most commonly used were linear, stepwise and alternate; 
therefore the other methods were combined to have four profile types in the analysis. All 
studies were randomised cross over trials.  (17), (22) and (21) satisfied all 12 quality criteria. Two 
studies satisfied 11 of the 12 quality criteria (13, 19), four studies met 10 of the 12 quality 
criteria (12, 14, 16, 20) and one study met 9 of the 12 quality criteria (15), as a result, no studies 
were excluded from the review. 
Data Abstraction 
All data were abstracted with a standardised data collection form. The following data were 
collected for each trial: type of randomization, sample size, sequence generation, allocation 
concealment, blinding, incomplete outcome data, attrition, analysis consideration, free of 
selective reporting, washout, profile type.  Confounding factors, such as washout used in 
cross over trials and hypotensive prone patients included were also recorded. 
Synthesis 
Stata 11.2 (Stata Corp) was used to analyse the data using the random effects method and for 
comparison and sensitivity analysis, the generic inverse variance method (24) .  Actual 
numbers of hypotensive events were pooled between studies and odds ratios have been used 
for the meta-analysis.  Further analyses of subgroups were performed on sodium profile type.  
Forest plots have been presented to show the extent of the variation in the studies and the I2 
statistic used to test heterogeneity.  The data were further investigated using meta-regression. 
In particular, meta-regression was used to test the hypothesis around the effect of profile 
types on outcomes.  Publication bias was tested using the Egger’s test (25) and a funnel plot 
has also been presented. 
RESULTS 
Characteristics of the studies 
Each paper was analysed for the patient type and dialysis treatment for comparison (Table 2).  
The mean age of patients ranged from 45 to 71 with the exception of Sadowski (22) whose 
participants were aged between 16-32 years of age.  The majority of papers used a dialysis 
protocol of 4 hour consecutive dialysis sessions of between 6-12 sessions (thrice weekly) 
again with the expectation of one paper (22) that had a protocol of 1.5-3 hour dialysis session 
according to kinetic modelling.  One paper (13) did not state the length of each dialysis session 
or the frequency of dialysis treatments.  As regards dialysate, most studies had similar 
dialysate compositions, only one study (14) did not state the dialysate used. 
Afferent and efferent dialysate sodium levels were included in only two studies (12, 17).  
Sodium levels were measured using ion selective electrodes, however three studies did not 
state their method of sodium analysis (14, 19, 20).  Only six studies analysed pre-dialysis sodium 
levels (12, 13, 15-17, 21).  
There is a tendency for thermal energy to accumulate during dialysis and therefore 
temperature needs to be controlled. Heat removal is generally controlled by dialysate and 
patient temperatures (26).  Dialysate temperatures have been provided by seven authors (12, 13, 
15, 16, 19-21).  As low body temperatures are common it is recommended that dialysate 
temperatures are less than 36°C to maintain reasonable temperature gradients (27), however 
the studies that presented this data, reported dialysate temperatures between 36-37°C, 
however it can be argued that dialysis treatment itself can provide cooling even with dialysate 
temperatures of 37°C. Extracorporeal blood flow assists with thermal regulation, however 
data were only found in seven of the ten studies and flow ranged from 200-400mls/min (12, 13, 
16, 17, 19, 20, 22).  
Most studies declared that they had excluded patients with co-morbidities with two 
exceptions (14, 19), however they were all cross over trials with the patients being their own 
control.  Most studies recruited participants that had diabetes (13-16, 19-21), however did not state 
whether they had accounted for the glucose effect 
There was limited information from some studies as regards chemistries and bioimpedance 
data was limited from most of the studies, those data that were found are presented for 
comparison (Table 3).  
Within study definitions of symptomatic hypotension were similar across studies (Table 4) 
with some exceptions (14, 19, 21, 22). 
 
The characteristics of the studies included in the meta-analysis can be found in Table 5.  As 
some studies investigated more than one sodium profile type and compared the results to the 
control, there are 13 datasets that have been included in the meta-analysis. 
All the studies included in the meta-analysis were cross over design trials, however all but 
four studies (16, 20-22)  had a washout period between treatment and control.  Two studies had 
only participants that were not prone to hypotensive events (12, 17), seven studies included 
those who were prone to hypotensive events during dialysis (13-16, 19-21).  One study did not 
stipulate haemodynamic status in the inclusion criteria (22) and this study had age ranges from 
16 to 32 (young adults) who did not have diabetes or cardiovascular disease.  The other 
studies did not make this stipulation in the inclusion criteria.   
Meta-analysis 
The number of haemodialysis sessions from the control phase of all the studies was 1,847 and 
from the intervention phase was 1,813, making 3,660 total dialysis sessions from all the 
studies combined. 
The risk difference was calculated for each study and ranged from reducing the risk of having 
a hypotensive event from 1.25 percentage points to 12 percentage points.  Two studies found 
that the risk of having a hypotensive event on intervention increased and ranged from 1.08 
percentage points to 8.6 percentage points. 
Odds ratios from the individual studies ranged from 0.15 to 2.57 (Figure 2).  Two studies had 
estimates that suggested increased hypotensive events with sodium profiling (20, 22).  The 
overall benefit of sodium profiling had a combined odds ratio of 0.71 (95% CI: 0.60 to 0.85) 
using the inverse variance fixed effects method, and 0.73 (95% CI: 0.56 to 0.95) using the 
random effects method.  There was moderate heterogeneity between the studies (I2: 47.2%; 
p=0.030). 
Type of profile was sub divided into groups (Figure 3).  The ‘other’ profile group had a 
pooled odds ratio of 0.48 (95% CI: 0.30 to 0.78), the stepwise group had pooled odds ratio of 
0.58 (95% CI: 0.44 to 0.76), the linear group had pooled odds ratio of 1.01 (95% CI: 0.77 to 
1.32) and alternate 0.67 (95% CI: 0.25 to 1.74).  Performing linear and alternate profiling did 
not consistently demonstrate reduction of hypotensive events during dialysis and two studies 
were found to favour control (conventional dialysis) over linear profiling.  Overall, using 
another type of profile method other than linear was shown to be beneficial, although some 
studies did cross the line of no effect.  
Performing stepwise and other profile type did show overall reduction in hypotensive events 
compared to standard dialysis; however some studies did cross the line of no effect.  The test 
of interaction based on this grouping was significant (p=0.012).   
Heterogeneity between the studies was expected as the studies differed in treatment, design 
and participants’ age ranges. There were in total six different profile types (two were grouped 
into one category labelled ‘other’ for ease of analysis).  When these studies were grouped into 
profile type, considerable heterogeneity was found (p=0.012).   
Publication bias 
Publication bias was tested using the Egger’s plot (25) and showed some symmetry (Egger’s 
bias coefficient =0.322; 95% CI: -2.69 to 3.34; p=0.82).  The funnel plot (Figure 4) 
demonstrates the smaller studies are closer to the bottom and further from the central line as 
expected.  The larger studies are closer to the central line.  Therefore there was no evidence 
of overestimation of the intervention effect in the meta-analysis and little evidence of 
publication bias. 
DISCUSSION 
Maintaining effective dialysis regimes has been shown to reduce mortality rates (8) and 
therefore it is important to discover techniques which aid in this treatment.  This meta-
analysis has demonstrated that some profiling methods reduced intradialytic hypotensive 
events compared to conventional dialysis.  Using stepwise profiling is better at reducing 
intradialytic symptoms than linear or alternate profiling. There was no evidence that linear 
profiling method was better than conventional dialysis and in fact the results showed that 
conventional dialysis was the better method (p=0.026), with two studies showing increased 
intradialytic hypotensive events during the linear profile phase.   
Donnan coefficient profiling method and the exponential profiling method (the two studies 
that were grouped into the ‘other’ category) were also shown to be of benefit; however one of 
these studies used only haemodynamically stable participants that were not prone to 
intradialytic hypotensive events and this may have impacted on the results. 
This meta-analysis showed considerable heterogeneity of the studies.  This though makes it 
difficult to compare and combine studies and to pool their data to perform a meta-analysis.  It 
may have been beneficial to have concentrated on one sodium profile type. 
It has been questioned that sodium profiling could lead to sodium loading (28) which is 
associated with increased interdialytic weight gain (IDWG), however with most studies 
sodium plasma levels did not change significantly pre and post dialysis (table 3).  It is unclear 
as to the degree which IDWG can impact on health outcomes (29) however only one study had 
shown an increase in IDWG using a profiled techniques (13). 
The results of this meta-analysis may have implications to clinical practice.  Currently it is 
accepted that profiling sodium levels are of benefit above conventional dialysis in those 
patients that are prone to intradialytic hypotensive events, however this may not be the case 
with all sodium profile methods and this needs to be highlighted.  An effective method that is 
supported by the UK Renal Association (11) is stepwise profiling and this should be adopted 
above linear in clinical practice. 
One issue that was not discussed by any of the studies included in this meta-analysis was the 
patient experience.  It may be that hypotensive events are reduced, but if other symptoms are 
produced by profiling that may adversely impact on the overall treatment experience, then 
this needs to be considered when deciding on treatment options. 
Limitations 
A limitation of this meta-analysis was using cross over design studies as they are inherent 
with problems of pooling data for meta-analysis (30).  However no studies could be found, 
using the search criteria outlined earlier, that were not cross over in design.  Another 
limitation was that in some studies two intervention groups were compared to their own 
control and these were then taken and used as separate studies for this meta-analysis.  This 
could have altered the results due to the carry-over effect, however all studies that did not 
have a washout period detailed minimising the carry-over effect during their trial.  Having 
repeated measures on one individual can lead to unit of analysis error.  This can be overcome 
by using tests that account for this such as paired analysis or Crossover ANOVA (30) as all but 
one of the studies used. 
CONCLUSION 
Dialysis regimes can contribute to episodes of intra-dialytic hypotension which can reduce 
the effectiveness of the treatment regime and lead to poor health outcomes.  To ensure that 
treatment is manged effectively, sodium profiling techniques need to be assessed to 
determine if they have a positive impact on patient outcomes. However, there has been little 
evaluation of sodium profiling techniques to determine their impact on patient outcomes.  
This review found that there are a number of sodium profiling techniques used in dialysis 
units but there is variability in the effectiveness of these techniques.  The techniques found to 
be most effective were the stepwise method, the Donnan coefficient and the exponential 
profiling technique. Recommendations from this review are that stepwise profiling should be 
adopted in clinical practice. 
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Figure Legends 
Figure 1. Inclusion and exclusion diagram for articles selected for meta-analysis 
Figure 2. Forest plot showing odds ratios of sodium profiling on hypotensive events using 
inverse variance fixed effects method and random method.  
Figure 3. Forest plot showing odds ratios of subgroups of profile types. 
Figure 4. Funnel plot with pseudo 95% confidence limits
Table 1. Adapted Cochrane Collaboration’s tool for assessing risk of bias 
 
 
 
 Study 
 
Design Sequence 
generation 
Allocation concealment Blinding  Incomplete 
outcome data 
Attrition rate Analysis consideration Free of selective 
reporting 
Other sources 
of bias 
Quality 
score 
 
De Paula 
2004 
 
Prospective non-
randomised cross 
over trial 
No No ‘Participants 
not aware of 
modification in 
dialysate Na+’ 
No  0% ITT analysis is followed 
in those excluded from 
trial 
Yes Unclear  Good 
Meira  2010 
 
Prospective 
randomised cross 
over trial 
Simple number 
drawing 
Unclear Unclear No 0% Results included all 
participants 
Yes No Good 
 
Meira 2007 
 
 
Prospective cross 
over trial 
Unclear Unclear Unclear Yes 22% 
Study reports 3 
lost but number 
does not match 
number 
analysed 
Unclear Yes Unclear Fair 
 
Moret 2006 
 
Prospective 
randomised cross 
over trial 
No Unclear Unclear No 16% 
Reasons for 
missing data 
unlikely to be 
related to true 
outcome 
No. Conducts only a per 
protocol analysis with 
≤95% of randomised 
patients analysed in 
allocation group 
Yes Unclear Fair 
 
Zhou 2006 
 
 
Prospective 
randomised cross 
over trial 
‘performed random 
allocation’ 
Unclear Unclear Yes- 11 sessions 
missing as did not 
meet criterion for 
interdialytic weight 
0% Unclear Yes No Fair 
 
Straver 2002 
 
 
Prospective cross 
over trial 
No No Unclear No 0% Results included all 
participants 
Yes Unclear Fair 
 
Hamzi 2012 
 
Prospective cross 
over trial 
No No Unclear Missing data not 
mentioned 
22% Unclear Yes Unclear Fair 
 
Oliver 2001 
 
 
Prospective  
randomised 
cross over trial 
Random number 
tables 
Unclear Yes- ‘both staff 
and patients 
were blinded’ 
Unclear 3% As per study protocol.  
ITT analysis not followed 
Yes No Good 
 
Sadowski 1993 
 
Prospective 
randomised cross 
over trial 
‘Random allocation’ Unclear ‘Patients 
blinded’ 
Yes 11% ITT analysis followed Yes No Good 
 
Song 2005 
 
Prospective 
randomised cross 
over trial 
‘Random allocation’ Unclear Unclear No 27% ITT analysis followed Yes No Fair 
Author Mean Age Co-morbidity scores Dialysis treatment  Pre dialysis weight (kg) 
(mean. SD) 
Adequacy Dialysate mmols/l 
 
Dialysate 
temperature 
de Paula 2004 46±14 Stable condition 9 consecutive 4 hour dialysis sessions for 
each phase (thrice weekly) 
Not stated Kt/V >1.2 HCO3- 33 
K+ 2.0 
Ca 1.75 
Mg 0.5  
Not stated 
Meira 2010 61.2±15.2 Not stated 12 consecutive 4 hour dialysis sessions for 
each phase (thrice weekly) 
Control 73.7±15.9 
Stepwise 74.1±16.4 
Linear 74.5±16.4 
Kt/V >1.2 HCO3- 33 
K+ 2.5 
Ca 3.5 
Mg 0.5 
36-36.5°C 
Meira 2007 59.9±12.6 Not stated 12 consecutive 4 hour dialysis sessions for 
each phase (thrice weekly) 
Not stated Not stated Not stated Not stated 
Moret 2006 71±11 Included patients with CHF and 
diabetes who were in a stable 
condition 
11 consecutive 4 hour dialysis sessions for 
each phase (thrice weekly) 
Not stated Kt/V >1.2 HCO3- 32 
K+ 2.0 
Ca 1.5 
Mg 0.5 
36°C 
Zhou 2006 52±9 Patients with co-morbidities 
excluded 
10 consecutive 4 hour dialysis sessions for 
each phase (thrice weekly) 
56.5± 8.0 Kt/V >1.2 HCO3- 33 
K+ 2.5 
Ca 1.75 
Mg 0.5 
37°C 
Straver 2002 63±6 Haemodynamically stable 1, 4 hour dialysis session for each phase 
conducted on the same day each week 
Not stated Kt/V 1.07±0.02 Bicarbonate buffer 37°C 
Hamzi 2012 45.2±11.4 Stable condition 
Co-morbidities excluded 
10 consecutive 4 hour dialysis sessions for 
each phase (thrice weekly) 
Control 62.14±7.5 
Profile 62.02±7.3 
Kt/V >1.14 HCO3- 29 
K+ 2.0 
Ca 1.50 
Mg 0.5 
37°C 
Oliver 2001 69.47 Stable condition 6 consecutive 4 hour dialysis sessions for 
each phase (thrice weekly) 
Control 71.7 
Profile 72.1 
URR 69.9 HCO3- 35 
Ca 2.5 
36.5 
Sadowski 1993 19 Stable condition 6 consecutive 1.5-3 hour dialysis sessions 
(determined by kinetic modelling) for each 
phase (thrice weekly) 
Not stated Kt/V 1.29±0.25 Bicarbonate based 
dialysate 
Not stated 
Song 2005 54±9 Stable condition 6 week treatment period 49.1±8.9 Kt/V 1.23±0.11 HCO3- 30 
K+ 2.5 
Ca 1.75 
Mg 0.75 
37°C 
Table 2. Within study patient characteristics and treatment characteristics 
 
 
 
 
 
Table 3. Pre, post and intradialytic chemistries and measurements 
 
 
 
 
 
Author IDWG  
(mean, SD) 
 
Pre dialysis BP (mean, SD) Post dialysis BP (mean, SD) Pre dialysis plasma Sodium 
(mean, SD)  
Post dialysis plasma sodium 
(mean, SD) 
Sodium concentration 
(mmols/l) 
Hb (g/dl) 
(mean, SD) 
Protein 
(g/dl) 
(mean, 
SD) 
Albumin 
(g/dl) 
(mean, 
SD) 
Hypotensive events (%) 
Control Profile Control Profile Control Profile Control  Profile Control Profile Control Profile 
de Paula 
2004 
Control 2.91±0.87 
Profile 2.29±0.87 
147±19/85±13 146±19/85±12 124±15/73±11 123±17/ 
74±9 
134.0±1.4 134.0±1.5 135.9±2.0 133.1±2.6 138 Initial 138 
End 126 
Not stated Not stated Not stated 9 2 
Meira 
2010 
Control 3.00(1.98-4.34 
Stepwise 2.96 (2.00-4.13) 
Linear 2.91 (1.93-4.41) 
149±18/85±13 Stepwise 
148±22/83±13 
Linear 
147±21/82±12 
 128±21/75±11 Stepwise 
127±20/ 
74±11 
Linear 
123±22/ 
73±12 
Not stated Not stated Not stated Not stated 139 147-stepwise 
138-linear 
Control  
121±20 
Stepwise 
117±15 
Linear  
117±16 
Not stated Not stated 25.8 Stepwise 13.6 
Linear 22.7 
Meira 
2007 
Control 2.78±1.0 
Profile 2.5±1.1 
149.5±23.5/84.1±1
2.2 
154.5±25.4/86.
4±13.4 
136.8±22.3/ 
80.3±11.4 
140.7±23.4/
78.2±10.7 
Not stated Not stated Not stated Not stated 139 Initial 147 
End 139 
Not stated Not stated Not stated 67.7 53.2 
Moret 
2006 
Control 2.0±1.0 
Profile 2.1±1.0 
Systolic 146±26 Systolic 
144±22 
 Not difference between various 
modalities 
 
138±2 139±3 Not stated Not stated 140 Initial 150 
End 140 
Not stated Not stated 3.82±3.8 16 14 
Zhou 
2006 
Control 2.91±0.6 
Profile 2.96±0.81 
MBP- 
100.78±10.32 
MBP- 
99.10±10.05 
Greater stability of MBP in the 
profile group 
138.00±2.7 137.17±1.8 138.75±2.3 137.65±1.9 138 Initial 148  
End 131 
10.57±1.6 7.26±1.19 3.32±0.9 20 18.75 
Straver 
2002 
 
Not stated MBP 94±7 MBP 97±4  MBP 79±5 91±3 140.1±0.7 140.0±0.7 Not stated Not stated 141 Initial 152 
End 130 
 Not stated  Not stated Not stated 25 0 
Hamzi 
2012 
Control 2.09±0.5 
Profile 2.2±0.47 
134±13/66±12 138±16/64±12 128±16/65±10 128±17/ 
60±19 
Not stated Not stated Not stated Not stated 139 Initial 147 
End 131 
Not stated Not stated Not stated 9 15 
Oliver 
2001 
Not stated 151/79 149/78 134/74 137/76 137 137.3 139.7 141.0 142 Initial 152 
End 142 
11.5 Not stated 3.647 20 13 
Sadowski 
1993 
Not stated Not stated Not stated  Not stated Not stated Not stated Not stated Not stated Not stated 138 Initial 148 
End 138 
Not stated Not stated Not stated 26.3 Stepwise 17.0 
Linear 27.1 
Song 
2005 
Control 2.7±0.6 
Stepwise 3.9±0.6 
Alternate 3.5±0.5 
148±17/85±8 Stepwise 
149±19/86±10 
Alternate 
144±16/84±8 
 
126±15/75±9 Stepwise 
137±20/ 
77±10 
Alternate 
136±19/ 
75±10 
138.1±0.3 Stepwise 
138±0.5 
Alternate 
138.1±0.7 
138.1±0.1 Stepwise 
140.4±0.4 
Alternate 
138.6±0.4 
138 Initial 148 
End 138 
8.7±1.1 6.8±0.5 3.4±0.3 36.4 Stepwise 18.2 
Alternate 18.2 
Author Working definition of symptomatic intradialytic hypotension 
de Paula 2004 Rapid changes in BP (within 15mins) accompanied by symptoms requiring nursing interventions, or a brisk fall in BP 
>40mmHg systolic or >20mmHg diastolic 
Meira 2010 No definition provided other than intradialytic symptomatic hypotension 
Meira 2007 No definition provided 
Moret 2006 Decline in systolic BP to <100mmHg or decline in systolic BP >30mmHg together with symptoms necessitating nursing 
interventions 
Zhou 206 Decrease in supine systolic BP of >30mmHg or an absolute systolic BP of <90mmHg during dialysis, accompanied by 
hypotensive symptoms such as dizziness, frequent yawning or perspiration 
Straver 2002 Decrease in supine systolic BP of >30mmHg or an absolute systolic BP of <90mmHg during dialysis, accompanied by 
hypotensive symptoms such as dizziness, frequent yawning or perspiration 
Hamzi 2012 Decrease in systolic BP >30mmHg 
Oliver 2001 Systolic BP <100mmHg, or dizziness, cramps, nausea, headache or other 
Sadowski 1993 Decrease in BP temporally associated with symptoms 
Song 2005 Systolic BP <90mmHg or a decrease of >30mmHg or an event that required immediate intervention 
Table 4. Definitions of symptomatic hypotension 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
Table 5. Characteristics of the studies included in the Meta-Analysis (* Risk difference; †Numbers needed to treat) 
 
 
 
Author 
Year 
Trial Washout Hypotensive 
prone 
patients 
included 
Profile 
type 
Control Intervention RD* NNT† 
Hypo- 
tensive 
events 
Total 
HD 
sessions 
Hypo- 
tensive 
events 
Total 
HD 
sessions 
De Paula 
(2004) 
1 Yes No Other 23 333 6 333 -5.1% 19.6 
Meira (2010) 2 Yes Yes Stepwise 68 264 36 264 -12% 8.3 
3 Yes Yes Linear 68 264 60 264 -3.3% 30 
Meira (2007) 4 Yes Yes Stepwise 63 204 42 177 -7.2% 13.8 
Moret (2006) 5 Yes Yes Linear 18 110 16 110 -1.45% 68.9 
Zhou (2006) 6 No Yes Linear 16 80 15 80 -1.25 80 
Straver (2002) 7 Yes No Alternate 2 8 0 8 -25% 4 
Hamzi (2012) 8 No Yes Linear 9 140 21 140 +8.6% 11.62 
Oliver (2001) 9 No Yes Other 37 188 24 181 -6.4% 15.6 
Sadowski 
(1993) 
10 No Yes Linear 25 95 26 96 +1.08 92.6 
11 No Yes Stepwise 25 95 16 94 -8.9% 11.23 
Song (2005) 12 Yes Yes Stepwise 13 33 11 33 -5.6% 17.8 
13 Yes Yes Alternate 13 33 11 33 -5.6% 17.8 
